The Truths and Myths of Ketamine: Insights Following Matthew Perry’s Tragic Passing

,

 / 

Myths of Ketamine

In the aftermath of Matthew Perry’s untimely death, with the cause attributed to the “acute effects of ketamine,” medical experts are addressing common misconceptions surrounding the powerful drug.

Perry’s autopsy revealed a combination of factors contributing to his demise, including “coronary artery disease,” “buprenorphine effects,” and the presence of “prescription medications and loose pills” at his residence.

Truths and Myths of Ketamine

Initially recognized for its role as an anesthetic during surgical procedures, ketamine has evolved in recent years as a potential remedy for treatment-resistant depression.

The Alcohol and Drug Foundation categorizes ketamine as a “dissociative drug,” capable of inducing a sense of detachment from the body or physical surroundings. While also used recreationally, experts stress that ketamine is generally safe when used as prescribed.

According to Lewis Nelson, Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, the concentration of ketamine found in Perry’s blood was enough to cause loss of consciousness, leading to the tragic outcome. Notably, ketamine typically doesn’t cause death from cardiac or respiratory effects but can result in associated injuries.

Dispelling the Top 5 Myths of Ketamine

Myth 1: Ketamine is a New Treatment

Contrary to popular belief, ketamine has been utilized for over a decade in treating depression, post-traumatic stress disorder (PTSD), and pain. FDA approval dates back to 1970 for both human and animal anesthesia. Successful clinical trials prompted the FDA to approve ketamine as a medication for treatment-resistant depression in 2019.

Myth 2: Ketamine is Powerfully Addictive

While legally recognized as having the potential for abuse and dependence, experts like Bankole Johnson, CEO of Casa Privรฉe, deem ketamine only moderately addictive. Ketamine’s potential for behavioral or psychological dependence is acknowledged, but physical dependence is typically mild to moderate.

Myth 3: Ketamine Can be Self-Prescribed and Purchased Online

Experts emphasize that ketamine should only be obtained and administered by licensed medical professionals. Self-diagnosis is discouraged, and those considering ketamine treatment are advised to consult a doctor to ensure proper diagnosis and administration.

Myth 4: Intranasal or Micro-Dosing is Safe for Recreational Use

Despite perceptions that smaller doses of ketamine may be safer, experts caution against self-administration due to the risk of exceeding safe limits. Intranasal use may lead to more aggressive drug-seeking behavior and potential complications not present in a monitored medical setting.

Myth 5: It’s Hard to Kick the Habit

Experts contend that weaning off ketamine is generally not challenging due to its short half-life. Gradual dose titrations are recommended for both starting and stopping the medication, ensuring a safe and controlled transition.

Potential Dangers and Guidelines

While ketamine has shown promise in various therapeutic applications, it can pose dangers, especially when abused or mixed with other substances. Experts warn against the risks of developing dependence, potential adverse effects when mixed with other drugs, and the importance of proper diagnosis and administration.

In the wake of Matthew Perry’s tragic incident, the American Society Of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) has announced plans to publish guidelines for the safe use of ketamine, particularly for at-home use.

The organization underscores the importance of a specific patient profile, a close relationship with a physician, and in-office follow-up for those considering at-home ketamine use.

It remains crucial for individuals to differentiate between the various uses of ketamine, understanding that its application for anesthesia, depression treatment, and abuse involves distinct dosages and frequencies. As discussions around ketamine continue, the focus shifts toward fostering awareness, education, and responsible usage of this potent drug.


— Share —

— About the Author —

Leave a Reply

Up Next

The Mental Health Toll of Wordle: New York Times Game Raises Concerns, Therapists Warn

Myths of Ketamine

Wordle, the popular word game from The New York Times, is under scrutiny as therapists express concerns about the mental health toll of wordle. Despite being intended as a source of intellectual fun, Wordle and other games offered by the Times are reportedly causing anxiety and interfering with daily life for some individuals.

Journalist Tess Owen recently highlighted the issue, revealing that her therapist had flagged excessive gameplay as a concern for many patients. Owen admitted to downplaying the amount of time she spent on the Times’ word games, including Wordle, during therapy sessions.

The Times’ gaming section offers an array of word and number puzzles, including the Crossword, Spelling Bee, and Connections. However, Wordle stands out as the most popular among players, with over 8 billion plays in 2023 alone.

Up Next

Former Australian PM Scott Morrison Opens Up About Battling Anxiety During His Time in Office

Myths of Ketamine

In a candid revelation, former Australian Prime Minister Scott Morrison has disclosed his struggles with “debilitating” anxiety during his tenure in office. In an interview published by The Australian newspaper, Morrison spoke openly about the challenges he faced while governing, citing the immense stress of managing crises such as the COVID-19 pandemic and the 2019-2020 Black Summer bushfires.

The 55-year-old evangelical Christian, who led the conservative coalition until losing power in May 2022, described his anxiety as “agonizing” and acknowledged its profound impact on his well-being.

He attributed the buildup of stress to the demanding nature of his role, which involved long hours and contentious diplomatic relations, particularly with China.

Up Next

Gen Z Workers Struggle with Email Stress, Survey Finds

Myths of Ketamine

A recent survey reveals that email stress is disproportionately affecting Gen Z workers, with many feeling overwhelmed by the volume of messages they receive daily. Conducted by Babbel, a language learning platform, the survey of 2,000 U.S. office workers highlights the challenges faced by the youngest members of the workforce.

Gen Z Faces Email Stress

Key findings from the survey include:

Email Overload: A majority of respondents report feeling stressed by the volume of work emails they receive each day. However, Gen Z workers aged 18 to 24 are particularly impacted, with 36% admitting to having over 1,000 unread emails in their inbox.

Regrettable Emai

Up Next

Chinese Teen Diagnosed with ‘Love Brain’ After Calling Boyfriend Hundreds of Times Daily

Myths of Ketamine

An 18-year-old Chinese girl has been diagnosed with what experts are terming as “love brain” after bombarding her boyfriend with hundreds of calls and messages every day. This alarming diagnosis follows a tumultuous saga of obsession that spiraled out of control, leaving both the girl, identified only as Xiaoyu, and her boyfriend in distress.

According to a report by Yueniu News, Xiaoyu’s descent into the grips of obsession began innocuously enough during her first year at university. What started as a budding romance quickly morphed into an unhealthy fixation, as Xiaoyu’s incessant need for her boyfriend’s presence and attention grew increasingly demanding.

Dr. Du Na, a specialist at The Fourth Peopleโ€™s Hospital of Chengdu, disclosed the severity of Xiaoyu’s condition, revealing that she bombarded her boyfriend with over 100 phone calls in a single day.

Up Next

Ethical Concerns Surrounding Involuntary Mental Health Treatment Explored on WBUR’s On Point

Myths of Ketamine

In recent years, several states have implemented policy changes aimed at making involuntary commitment easier for individuals with severe mental illnesses. However, this shift has sparked intense debate, with critics arguing that forced mental health treatment can potentially do more harm than good to patients while raising significant civil rights questions.

This pressing ethical dilemma was the focus of a recent episode of WBUR’s On Point, aired on April 17, 2024. Hosted by Jonathan Chang and Deborah Becker, the program delved into various perspectives on involuntary mental health treatment, featuring insightful discussions with experts and individuals directly impacted by these policies.

Guests on the show included Will James, the host of KUOW and The Seattle Timesโ€™ โ€œLost Patientsโ€ podcast, and Dominic Sisti, an associate professor of medical ethic

Up Next

Chinese Retail Tycoon Introduces ‘Unhappy Leave’ Policy to Prioritize Employee Well-being

Myths of Ketamine

In a groundbreaking move towards prioritizing employee well-being, Chinese retail tycoon Pang Dong Lai has introduced an unconventional ‘unhappy leave’ policy.

Founder and chairman Yu Donglai announced that employees will be entitled to request up to 10 days of additional leave when feeling unhappy, emphasizing that “everyone has times when theyโ€™re not happy, so if youโ€™re not happy, do not come to work.”

Under this new policy, employees have the freedom to determine their rest time, and management cannot deny this leave, as stated by Yu Donglai, who believes that denial would constitute a violation.

The company’s employment policy also includes measures such as seven-hour workdays, weekends off, and generous annual leave, ranging from 30 to 40 days, with an additional five days off during the Lunar

Up Next

Companies Exploring Psychedelic Drug Therapy Coverage for Employees, Citing Mental Health Benefits

Myths of Ketamine

A recent report highlights a growing trend among companies to consider offering psychedelic drug therapy coverage for their employees as a cost-effective and potentially impactful solution for mental health treatment.

This emerging approach is fueled by recent research indicating the therapeutic potential of substances like MDMA, psilocybin, and ketamine in addressing various mental health issues, including depression, anxiety, and PTSD

Jorge Yant, the founder of Plexis Healthcare Systems, shared his perspective with The Wall Street Journal, revealing his decision to provide psychedelic-assisted therapy coverage to employees through the benefits startup Enthea. Yant’s motivation stemmed from an internal report revealing a high prevalence of prescription drug use, particularly antidepressants, among his staff.